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Available online 26 April 2014Abstract Pelota (Pelo) is ubiquitously expressed, and its genetic deletion in mice leads to embryonic lethality at an early
post-implantation stage. In the present study, we conditionally deleted Pelo and showed that PELO deficiency did not markedly
affect the self-renewal of embryonic stem cells (ESCs) or their capacity to differentiate in teratoma assays. However, their
differentiation into extraembryonic endoderm (ExEn) in embryoid bodies (EBs) was severely compromised. Conversely, forced
expression of Pelo in ESCs resulted in spontaneous differentiation toward the ExEn lineage. Failure of Pelo-deficient ESCs to
differentiate into ExEn was accompanied by the retained expression of pluripotency-related genes and alterations
in expression of components of the bone morphogenetic protein (BMP) signaling pathway. Further experiments have also
revealed that attenuated activity of BMP signaling is responsible for the impaired development of ExEn. The recovery of
ExEn and down-regulation of pluripotent genes in BMP4-treated Pelo-null EBs indicate that the failure of mutant cells to
down-regulate pluripotency-related genes in EBs is not a result of autonomous defect, but rather to failed signals from
surrounding ExEn lineage that induce the differentiation program. In vivo studies showed the presence of ExEn in Pelo-null
embryos at E6.5, yet embryonic lethality at E7.5, suggesting that PELO is not required for the induction of ExEn development,
but rather for ExEn maintenance or for terminal differentiation toward functional visceral endoderm which provides the
embryos with growth factors required for further development. Moreover, Pelo-null fibroblasts failed to reprogram toward
induced pluripotent stem cells (iPSCs) due to inactivation of BMP signaling and impaired mesenchymal-to-epithelial transition.
Thus, our results indicate that PELO plays an important role in the establishment of pluripotency and differentiation of ESCs
into ExEn lineage through activation of BMP signaling.
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62 G. Nyamsuren et al.Introduction Here, we generated a conditional knockout mouseTwo developmental processes take place during pre-
implantation in the development of mammalian embryos. The
outer cells of the morula differentiate into a trophoectoderm
(TE) lineage, whereas the inside cells become the inner cell
mass (ICM). Further development involves the specification
of the ICM into primitive endoderm (PrE), located on the
outside of the ICM, and into epiblast (EPI) that differentiates
during later embryonic development into all three germ layers,
including primordial germ cells (Cockburn and Rossant, 2010).
Around the time of implantation, PrE gives rise to extraem-
bryonic endoderm (ExEn), which contributes to visceral (VE)
and parietal endoderm (PE) (Tam and Loebel, 2007; Plusa
et al., 2008). VE and PE enclose and provide the developing
embryo with nutritive support and molecular signals that are
essential for cell fate decisions and axial pattern initiation
(Bielinska et al., 1999; Yamamoto et al., 2004). Genetic
ablation studies of genes involved in the development of
PrE or its derivatives revealed an early embryonic lethality
(Molkentin et al., 1997; Morrisey et al., 1998; Koutsourakis et
al., 1999; Yang et al., 2002). Recent reports revealed that the
differential expression of the pluripotency-related gene Nanog
and GATA family members Gata4 and Gata6 in ICM cells is
responsible for cell fate decisions regarding differentiation
into EPI and PrE, respectively (Chazaud et al., 2006). These
results confirm previous findings that showed the requirement
of Nanog for the establishment of EPI and for the suppression
of PrE differentiation (Mitsui et al., 2003), whereas Gata4
and Gata6 are crucial for the development of PrE and its
derivatives (Molkentin et al., 1997; Morrisey et al., 1998;
Koutsourakis et al., 1999; Cai et al., 2009).
Embryonic stem cells (ESCs), the in vitro counterpart
of ICM cells, are pluripotent and have the potential to
differentiate into all cell lineages of the early embryo;
hence, they are regarded as a valuable tool to understand
the molecular mechanisms governing early embryonic
development (Niwa, 2010). The embryoid body (EB) that is
formed during ESC differentiation in floating culture criti-
cally mimics the pre- and post-implantation developmental
stages of the embryo (Doetschman et al., 1985). This system
was successfully exploited to study and understand the ExEn
loss phenotype seen in a Gata6-knockout mouse model
(Capo-Chichi et al., 2005).
PELO is highly conserved in eukaryotes. In yeast, the
PELO-ortholog Dom34 and its interacting protein Hbs1 are the
core components of the newly described RNA surveillance
mechanism called No-Go decay (NGD) (Doma and Parker,
2006). NGD recognizesmRNAs on which the ribosome is stalled
at a stable stem-loop, rare codon, or pseudoknot, triggering
the endonucleolytic cleavage of these mRNAs (Graille et al.,
2008; Chen et al., 2010). Despite central function of the
Dom34:Hbs1 complex in NGD, neither of these proteins is
essential for yeast survival (Carr-Schmid et al., 2002). In
contrast, the deletion of Pelo results in embryonic lethality
beyond 6.5 dpc in mice. The in vitro culture of Pelo−/−
blastocysts revealed a failure of ICM to expand and give rise to
ESCs, suggesting that PELOmight be involved in the regulation
of the cell cycle or the self-renewal of a pluripotent ICM or
ESCs (Adham et al., 2003). The role of PELO in the control of
germ stem cell self-renewal has been described in the ovary of
Drosophila melanogaster (Xi et al., 2005).model to investigate the role of PELO in early embryonic
development and ESC pluripotency. We report that PELO is
dispensable for self-renewal of ESCs but is required for ESC
differentiation into ExEn. At the molecular level, we show
that the decreased activity of BMP signaling is responsible
for the impaired differentiation of ExEn in Pelo-deficient
EBs.
Material and methods
Generation of conditional Pelo knockout mice
The PeloF targeting construct was generated in the pPNT4
vector. In the PeloF targeting construct, two loxP sites were
inserted into intron 1 and the 3′-flanking region of Pelo to
allow Cre-mediated recombination and excision of exons 2 and
3 containing the coding sequences of Pelo. The 6.7- and 4.6-kb
long 5′- and 3′-flanking homologous arms, respectively, were
cloned into the targeting construct (Suppl. Fig. 1A). The
targeting vector was linearized with NotI and used for
transfection of RI ESCs. Neomycin-resistant ESC clones were
checked for homologous recombination by southern blot-
analysis. External probes (P1 and P2 in Suppl. Fig. 1A) were
used for hybridization of southern blots containing EcoRI-
and BsrGI-digested DNA (Suppl. Figs. 1B, C). To confirm the
absence of the additional insertion of targeting construct in
homologous recombinant ESCs, blots containing AseI-digested
DNA were probed with neomycin fragment (Suppl. Fig. 1D).
Cells from two correctly targeted ESC clones were micro-
injected into C57BL/6J blastocysts. Chimeric founders were
mated with C57BL/6J mice to generate heterozygous PeloF/+
mice, which were intercrossed with conventional Pelo+/−mice
to produce heterozygous PeloF/− mice. The Rosa26CreERT2
knock-in (Hameyer et al., 2007) and transgenic EIIa-Cre mice
(Lakso et al., 1996) were bred with PeloF/− mice to generate
inducible and constitutive Pelo-KO mice, respectively.
Genotyping of mice was carried out by PCR amplification
(Suppl. Fig. 1E). Primer sequences are listed in Suppl. Table 1.
All animal experiments were reviewed and approved by
the Institutional Animal Care and Use Committee of the
University of Göttingen.
Cell culture and teratoma formation assay
ESCs were maintained on Mitomycin C-treated MEF feeder
layers in LIF-supplemented medium as described previously
(Wurst and Joyner, 1993). For differentiation of ESCs into
EBs, a single-cell suspension of ESCs was incubated for
30 min on uncoated culture dishes to remove feeder cells.
Afterwards, ESCs (1 × 105 cells/cm2) were plated onto
bacteriological dishes and grown in ESC medium without
LIF. After 4 days of culture, EBs were fed with fresh medium
every second day and harvested at the indicated time
points. Alternatively, MEF-free ESCs were plated on
Aggriwell plates (STEMCELL Technologies) at a density of
1 × 105 cells/well. To determine whether the retinoic acid
(RA) induces the ExEn differentiation in Pelo-null EBs, ESCs
were allowed to aggregate and grown with 1 μM RA for
5 days. For culture of wild-type EBs with conditioned
medium derived from Pelo-deficient EB cultures, PeloΔ/−
63PELO regulates ExEn developmentESCs were seeded at 5 × 104 cells per 1 cm2 in Knockout™
DMEM medium supplemented with 20% Knockout™ serum
replacement (SR, Life Technology) on bacterial Petri dishes.
After 5 days of EB cultures, supernatants were collected,
filtered and used as a culture medium for EB formation of
wild-type ESCs. After 6 days, wild-type EBs were collected
and either fixed for immunohistological analysis or subject-
ed for RNA isolation.
To determine the effect of BMP4 and Noggin on the
development of ExEn, mutant PeloΔ/− and control PeloF/−
EBs were formed in serum replacement medium (SR)
supplemented with either 20 ng/ml recombinant BMP4
(Life Technology) or 150 ng/ml recombinant Noggin (Life
Technology), respectively.
To generate BMP responsive reporter cell line (PeloF/−
BRE-FFLuc), PeloF/− ESCs were transfected with the reporter
construct pBFIR containing BMP responsive element (BRE)
driven Firefly luciferase gene (FFLuc) and SV40 promoter/
enhancer driven Renilla luciferase (RRLuc) gene (Yadav et
al., 2012). The ESC clone (PeloF/− BRE-FFLuc) showing high
FFLuc activity in response to 20 ng/ml recombinant BMP4
was selected and cultured in medium containing 1 μM 4-OHT
to generate PeloΔ/− BRE-FFLuc cell line. The parental PeloF/−
BRE-FFLuc and the PeloΔ/− BRE-FFLuc ESCs were aggregated
in SR medium for 5 days, and the resulting EBs were then
treated for 12 h either with or without 20 ng/ml recombi-
nant BMP4. In another assay, PeloF/− BRE-FFLuc EBs were
cultured for 12 h with PeloΔ/− EBs conditioned medium
supplemented either with or without BMP4. Dual luciferase
assay was carried out according to the manufacturer's
recommendation (PJK GmbH, Kleinblittersdorf, Germany).
For teratoma formation assay, single-cell suspension of
cultured ESCs in PBS (4 × 106 cells in 100 μl PBS) was
subcutaneously injected into the flanks of immunodeficient
RAG2−/−gc−/− mice. After 4–7 weeks, teratomas were
excised, fixed, and subjected to histological analysis.
Generation of induced pluripotent stem cells
We used Yamanaka factors (retroviral expression vectors for
Oct3/4, Sox2, Klf4, and c-Myc) procured from Addgene to
generate iPSCs, as previously described (Takahashi and
Yamanaka, 2006). Briefly, MEFs isolated from transgenic
Nanog-EGFP (Okita et al., 2007), PeloF/+, PeloF/−, and
PeloΔ/− MEFs were transduced with retroviral particles, as
previously described (Xu et al., 2011). To establish iPSC
lines, colonies that appeared after 10 days of virus infection
were picked manually and cultured in 24-well plates under
standard ESC culture conditions. For rescue experiments,
PeloΔ/− MEFs were transduced with retroviral particles
expressing Pelo in addition to Yamanaka factors.
Generation of expression constructs
The pCAG-Pelo-IZ construct used for the overexpression of
Pelo in wild-type ESCs was generated by PCR amplification of
Pelo cDNA using primers Pelo-F and Pelo-R (Suppl. Table 3)
and cloning into the XhoI site of the pCAG-IZ vector. The
construct containing the stem loop-EGFP (pCAG-SL-EGFP-IZ)
was generated by PCR amplification and cloning of EGFP
cassette (lacking ATG-start codon) into EcoRI/SalI-digestedpBluescript vector to yield pBluescript-EGFP. Sequences
of primers (GFP-F and GFP-R) used for EGFP cassette
amplification are provided in Supplementary Table S1.
Next, the sense and anti-sense oligonucleotides SL-S and
SL-AS (Suppl. Table 1) containing the sequences of ATG and
stem-loop were annealed and cloned into the BamHI/
EcoRI-digested pBluescript-EGFP construct to generate
pBluescript-SL-EGFP. Finally, the XhoI/SalI fragment contain-
ing SL-EGFP fragment was cloned into XhoI-digested pCAGIZ
vector to generate pCAG-SL-EGFP-IZ. The retroviral construct
of Pelo (pMXs-Pelo) was generated by PCR amplification of
Pelo cDNA using pcDNA 3.1-Myc-Pelo (Burnicka-Turek et al.,
2010) as a template and cloning into EcoRI restriction sites of
the pMX vector.
RNA isolation, RT-PCR, qRT-PCR, and northern blot
analysis
Total RNA was extracted using an RNeasy mini-kit (Qiagen,
Germany) or NucleoSpin miRNA kit (Macherey-Nagel,
Germany) by following the manufacturer's protocols. For
mRNA expression analysis, 5 μg total RNA was processed for
cDNA synthesis using the SuperScript II system (Invitrogen,
Germany). For miRNA quantification assays, 1 μg total RNA
was used for cDNA synthesis using the miScript II RT Kit
(Qiagen). For qRT-PCR analysis, diluted cDNA (1:10) was
used as a template in a QuantiFast SYBR Green (Qiagen)
reaction and run in an ABI 7900HT Real-Time PCR System
(Applied Biosystems). Expression data were first normalized
to housekeeping genes (Hprt or Sdha) and represented as
relative expression to one of the cell types. For northern blot
analysis, 15 μg total RNA was resolved on an agarose gel
containing formaldehyde, transferred onto a nylon mem-
brane, and hybridized with Pelo cDNA and EGFP probes
(Shamsadin et al., 2002). All experiments were indepen-
dently replicated at least two times. Primers used for
RT-PCR and qRT-PCR analyses are listed in Supplementary
Tables S2 and S3.
To assay Noggin mRNA stability in control and mutant
cells, EBs were treated with 10 μg/ml of actinomycin D, and
total RNA was extracted after 0, 0.5, 2, 4, and 8 h of the
treatment. Northern blots with RNAs isolated from ESCs and
EBs were hybridized with Noggin cDNA probe. Hybridization
signals were quantified by ImageJ software (NIH, Bethesda,
MD, USA). Optic density of Noggin mRNA levels at each
time point was normalized to Elongation factor-2 transcript
levels.
Cell proliferation, apoptosis and cell cycle analysis
To determine cell proliferation, we used the CellTiter 96
AQueous Non-Radioactive Cell Proliferation Assay Kit (Promega,
Madison,WI). Briefly, ESCswere plated at a density of 500 cells/
well in gelatin-coated 96-well plates. After 2, 4, and 6 days of
culture, cell proliferation was measured after incubation with
MTS reagent. The absorbance was detected at 490 nm with a
Microplate Reader. Results are presented as the mean
absorbance of three independent experiments.
To verify the apoptosis, single-cell suspensions were
labeled for Annexin-V and 7-amino-actinomycin D (7-AAD)
staining using an Annexin V-PE Apoptosis Detection Kit I (BD
64 G. Nyamsuren et al.Biosciences), following the manufacturer's instructions.
After staining, flow cytometric measurements were per-
formed on a FACSCalibur flow cytometer and analyzed with
CellQuestPro software (BD Biosciences).
For cell cycle analysis, ESCs were trypsinized and washed
with PBS followed by ethanol fixation at 20 °C for a minimum
of 2 h. After fixation, the cells were washed, resuspended in
PBS containing 10 mg/ml propidium iodide (PI) and 1 mg/ml
RNase A, and incubated at 37 °C for 30 min. After incubation,
cells were measured on a FACSCalibur flow cytometer and
analyzed after exclusion of cell doublets. All experiments
were performed in three independent experiments.
Immunostaining and alkaline phosphatase staining
ESCs grown on cover slips were washed with phosphate-
buffered saline (PBS) and fixed with 4% paraformaldehyde
(PFA) at 4 °C for 30 min. EBs were fixed with 4% PFA at 4 °C
for 1 h, washed with PBS, incubated with 30% sucrose
at 4 °C, embedded in OCT, and cryosectioned at a 10-μm
thickness. Deciduae were isolated at E6.5 and E7.5 from
females of heterozygous Pelo+/− breeding, fixed overnight in
4% PFA at 4 °C, dehydrated and embedded in paraffin.
Sections (5 μm) were either stained with hematoxylin and
eosin (H&E) or subjected to immunohistological analysis.
Cells or sections were permeabilized and blocked using PBS
containing 0.1% Triton X-100 and 1% goat serum for 1 h. The
primary antibodies were diluted in blocking buffer and
incubated with cells or slides at 4 °C overnight. The next
day, cells or slides were washed with PBS followed by
incubation with secondary antibodies conjugated to fluores-
cent dyes. Images were acquired using an Olympus BX60
microscope (Olympus, Germany).
Cytochemical staining for alkaline phosphatase (AP)
activity was performed using a Leukocyte Alkaline Phospha-
tase Kit (Sigma-Aldrich, Germany), according to the
manufacturer's instructions.
Western blotting
Total protein isolation, separation by SDS-PAGE, and sub-
sequent western blotting were performed as previously
described (Xu et al., 2011). Antibodies used for western
blot analysis and their sources are listed in Supplementary
Table 4.
To determine the levels of Noggin in the conditioned
medium, wild-type and Pelo-null EBs were cultured in SR
medium. Conditioned medium was concentrated with
Centrisart® I ultrafiltration unit (Sartorius, Germany). For
semiquantitation of Noggin protein, equal amount of
concentrates was loaded onto SDS/PAGE gel and blot was
incubated with goat anti-mouse Noggin antibody (R&D
systems).
TGF-β/BMP PCR array
Amouse TGFβ/BMP Signaling Pathway PCR array (SABiosciences,
PAMM-035) was used to analyze the expression levels of BMP
signaling pathway components in PeloF/− and PeloΔ/− EBs. Briefly,
total RNA was isolated from PeloF/− and PeloΔ/− EBs after 5 days
of ESC culture under differentiation conditions as describedabove. Subsequently, 5 μg total RNA was used for
first-strand cDNA synthesis with the RT2 first strand kit
(Qiagen, Germany). The PCR array was carried out
following the manufacturer's instructions using the ready-
to-use RT2-qPCR master mix (RT2-SYBR® Green/Fluores-
cein qPCR master mix, SABiosciences, Germany). Twenty-
five microliters of the experimental cocktail was added
into each well containing pre-dispensed, gene-specific
primer pairs and run on an ABI 7900HT fast quantitative
PCR system. Data analysis was performed using the
web-based standard RT PCR array suite (SABiosciences,
Germany).
Statistical analysis
All qPCR data for RNA expression analysis (two or more
biological replicates) were calculated using the standard
curve method. A two-way ANOVA (GraphPad Prism 4.0) test
was used to obtain calculations of statistical significance.
Results
PELO is essential for the development of
ExEn lineage
To elucidate the function of Pelo in pluripotency and ESC
differentiation potential, we generated a conditional Pelo
construct containing two loxP elements flanking exons 2 and 3
of Pelo (Suppl. Fig. 1A). A floxed allele (PeloF) was generated in
mouse ESCs by homologous recombination (Suppl. Figs. 1A–D).
Injection of PeloF/+ ESCs into blastocysts resulted in chimeric
mice, and further breeding with conventional heterozygous
Pelo+/− established PeloF/−, whereas inbreeding with PeloF/+
established PeloF/F animals. The PeloF/F and PeloF/− mice
appeared normal and were fertile, indicating that the insertion
of loxP and the neo-cassette did not disrupt the Pelo locus.
Genetic depletion of Pelo in one cell-stage embryos was
accomplished by breeding PeloF/F with EIIa-Cre-deleter mice
and an F1 generation intercross of Pelo Δ/+EIIa-Cre mice.
Similar to the post-implantation lethality of conventional
Pelo−/− embryos, genotyping of more than 100 embryos at
E8.5 did not lead to the identification of any homozygous
PeloΔ/Δ embryos (data not shown), indicating that deletion of
the floxed region in PeloΔ/Δ embryos at the one-cell stage
results in lethality.
To examine the consequence of Pelo deletion on ESC
pluripotency and development of pre-implantation embryos,
PeloF/− mice were crossed with mice harboring a knock-in
Rosa 26-CreERT2 allele to obtain mice of the compound
genotype PeloF/−CreERT2 and PeloF/F CreERT2.
We established PeloF/−CreERT2 ESC lines that were
derived from the ICM of blastocysts of PeloF/−CreERT2 mice
interbreeding. Upon 4-hydroxytamoxifen (4-OHT) treat-
ment, Cre-mediated deletion of floxed Pelo generated a
null allele (PeloΔ), as verified by PCR (Suppl. Fig. 1E).
Northern and western blot analyses confirmed the absence
of the Pelo transcript and protein in PeloΔ/− ESCs (Suppl.
Figs. 1F, G). Pelo-deficient ESCs exhibited normal colony
morphology and unlimited proliferation in culture, but
exhibiting slightly slower growth (Suppl. Fig. 2A). However,
no alterations in the proportion of apoptotic cells were
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7-aminoactinomycin D (7-AAD) staining by fluorescence-
activated cell sorting (FACS) (Suppl. Fig. 2B). Furthermore,
no significant differences were observed in the analyzed cell
cycle parameters between control and Pelo-null ESCs (Suppl.
Fig. 2C). The finding that the deletion of Pelo in established
ESC lines did not significantly affect their viability was
surprising, given that the conventional Pelo−/− ICM failed to
expand its pluripotent cell population (Adham et al., 2003).
Therefore, we studied the differentiation potential of
mutant ESCs in formed embryoid bodies (EBs). In contrast
with control PeloF/− EBs, most of the mutant PeloΔ/− EBs
failed to form a distinct outer layer of ExEn (Fig. 1A). We
have determined the expression of several pluripotency and
ExEn markers in control and mutant ESCs and EBs. No
significant differences in expression levels of pluripotency
genes were observed between mutant and control ESCs
(Fig. 1C). The attenuated levels of c-Myc expression in
mutant ESCs compared to that in control ESCs may explain
the slightly slower growth of Pelo-deficient ESCs. Expression of
pluripotency genes was markedly reduced in control PeloF/−
EBs, as expected (Fig. 1C). In contrast, pluripotency genes
persist to express at high levels in Pelo-deficient EBs, even after
15 days of differentiation (Fig. 1C). Immunoblot analysis
further confirmed the expression of OCT4 (also known as
POU5F1) in Pelo-deficient EBs (Fig. 1B). Furthermore,
re-plating of cells derived from 15-day-old PeloΔ/− EBs formed
typical ESC colonies and expressed OCT4, whereas control
PeloF/− cells failed to form colonies (Suppl. Figs. 3A–D).Figure 1 Failure of Pelo-deficient ESCs to differentiate into ExEn
mutant PeloΔ/− EBs on days 5 (EB5) and 15 (EB15) of differentiation. (
and EBs. (C) Quantitative real-time PCR analysis for the expression o
on day 15 of differentiation. (D) Quantitative RT-PCR analysis of the
Values of expression levels in C and D normalized to Hprt or Sdha are
of control ESCs were expressed as 1.0. *, significantly different fromTo confirm the impaired differentiation of ExEn in mutant
PeloΔ/− EBs, we investigated the expression levels of marker
genes for differentiation of ExEn lineage. As shown in Fig. 1D,
expression levels of ExEn marker genes Gata6, Gata4, Hnf4,
Afp, and Dab2 were significantly reduced in mutant EBs.
Immunostaining of histological sections of EBs revealed that
expression of PELO and ExEn markers DAB2 and GATA4 is
localized on the outer layer of control EBs, whereas PELO-,
DAB2-, and GATA4-positive cells were mainly lacking in
mutant EBs (Fig. 2A). Collectively, these results indicate a
requirement of PELO for the development of ExEn lineage. We
then investigated the consequence of Pelo deficiency on the
temporal expression of genes associated with pluripotency,
early and late stages of ExEn differentiation during EB
formation (Fig. 2B). No significant differences in expression
levels of pluripotency-related genes, Nanog and Oct4, in
mutant and control EBs after 2 and 3 days of culture were
observed. Similarly, there were no differences in the
expression of early ExEn markers, Gata4 and Gata6, after
3 days. After 4 days of EB formation, the expression of Nanog
and Oct4was sharply down-regulated in control EBs compared
to that in mutant EBs. In contrast, expression levels of Gata4
and Gata6 were significantly elevated in control EBs, but not
in mutant EBs, after 5 days of culture (Fig. 2B). Unlike Gata4
und Gata6, the expression of Hnf4, a late ExEn marker, was
first activated in control EBs after 5 days of culture and
subsequently enhanced. However, expression of Hnf4
remained at low levels in Pelo-deficient EBs (Fig. 2B). The
observed expression changes of early and late ExEn markerslineage. (A) Phase-contrast micrographs of control PeloF/− and
B) Immunoblot for expression of OCT4 in PeloF/− and PeloΔ/− ESCs
f pluripotency marker genes in PeloF/− and PeloΔ/− ESCs and EBs
expression of ExEn markers in PeloF/− and PeloΔ/− ESCs and EBs.
presented as mean ± SD of three experiments. Transcript levels
control; p b 0.05.
Figure 2 Expression of Pelo and ExEn markers in control PeloF/− EBs, mutant PeloΔ/− EBs, and Pelo-overexpressing ESCs. (A) Paraffin
sections of PeloF/− and PeloΔ/− EBs on day 10 of differentiationwere immunostainedwith GATA4, DAB2, and PELO antibodies. Scale bars in
A: 20 μm. (B) Quantitative RT-PCR analysis for the temporal expression of pluripotency-related and ExEn markers in PeloF/− and PeloΔ/−
cells during EB formation. Expression levels normalized to Hprt are presented as mean ± SD of three experiments. Transcript levels of
control cells at day 0 of differentiationwere expressed as 1.0. *, significantly different from control; p b 0.05. (C) Immunoblot analysis for
the expression of GATA4 and DAB2 in PeloF/− and PeloΔ/− EBs, which were formed in the absence (−) or presence (+) of retinoic acid (RA).
(D) Total proteins isolated from EBs after 10 days of culture were analyzed by immunoblotting for the expression of pro-caspase (P. cas.3)
and cleaved caspase 3 (Cl. Cas.3). (E) Wild-type ESCs (+/+) and Pelo-overexpressing ESCs (+/+T) were cultured in the presence of LIF,
fixed, and immunostained with anti-DAB2 antibodies. The nuclei were stained with DAPI. (F) Expression levels of Pelo, pluripotency
and ExEn marker genes in PeloF/−, PeloΔ/− and Pelo-overexpressing (Pelo+/+T) ESCs were determined by qRT-PCR. Values of expression
levels normalized to Hprt are presented as mean ± SD of three experiments. Transcript levels of control ESCs were expressed as 1.0.
*, significantly different from control; p b 0.05. Scale bars in E: 100 μm.
66 G. Nyamsuren et al.during EB formation suggest that the development of the ExEn
is although induced in mutant EBs, but is not maintained to
late stages of EB formation. We further investigated whether
the impaired development of ExEn in Pelo-deficient EBs can be
restored by the activation of retinoic acid (RT) signaling
pathway. As shown in Fig. 2C, retinoic acid induces expression
of GATA4 and DAB2 in Pelo-null EBs in the same extent as in
control EBs, indicating that the RA treatment stimulates ExEn
differentiation in Pelo-null EBs. To examine whether the
impaired development of Pelo-null EBs is a result of increased
apoptosis, wemonitored apoptotic cell death by analyzing the
levels of cleaved caspase 3 in control and mutant EBs after
10 days of culture. Western blot analysis revealed no marked
difference in the protein levels of cleaved caspase 3 in both
control and mutant EBs (Fig. 2D).
These results prompted us to examine whether overex-
pression of Pelo in wild-type ESCs induces a differentiation
program toward ExEn. Pelo+/+ ESCs were stably transfected
with a pCAG-Pelo-IZ construct containing Pelo cDNA under the
control of CAG promoter. In contrast to typical ESC morphol-
ogy of empty vector-transfected cells, most Pelo-transfected
colonies displayed closely apposed, flattened cells similar tothe morphology of ExEn cells (Jetten et al., 1979) and were
positive for DAB2 (Fig. 2E). Quantitative RT-PCR revealed
that expression levels of Pelo in pCAG-Pelo-IZ-transfected
cells were 1.7-fold higher than that of empty vector-
transfected cells (Fig. 2F). In line with the DAB2 expression,
the expression of Gata4, Gata6 and Hnf4was strongly induced
in Pelo-overexpressing cells (Fig. 2F). To determine whether
increased expression of Pelo in ESCs restricts their fate to
an ExEn lineage, expression of pluripotency genes Oct4 and
Nanog was examined. As shown in Fig. 2F, the expression
of pluripotency marker genes was significantly reduced in
Pelo-overexpressing cells, indicating that increased Pelo
expression induces the differentiation of ESCs toward an
ExEn lineage.
To assess the differentiation capacity of mutant ESCs in
teratoma formation, we compared the teratoma-forming
ability of control and mutant ESCs in immunodeficient
Rag2−/− cg−/− mice. Both PeloF/− and PeloΔ/− ESCs formed
teratomas containing tissues derived from all three germ
layers (Suppl. Fig. S4). These results revealed the capacity
of Pelo-deficient ESCs to differentiate into cell lineages of
the three germ layers in a teratoma assay.
67PELO regulates ExEn developmentDisrupted development of ExEn in EBs derived from
mutant ESCs led us to investigate the development of ExEn
in Pelo-null embryos. Since Pelo-deficient embryos died
between E6.5 and E7.5 (Adham et al., 2003), we have
performed immunohistological analysis on sections of E6.5
and E7.5 embryos derived from breeding of heterozygous
Pelo+/− animals. As expected, PELO was ubiquitously
expressed in control embryos, but was undetectable in
Pelo−/− embryos (Suppl. Fig. 5A). Mutant E6.5 embryos were
markedly smaller than their heterozygous and wild-type
littermates. Although ExEn is formed in Pelo-deficient E6.5
embryos as indicated by the expression of GATA4 and DAB2,
the development of Pelo-null embryos at E7.5 was severely
affected, a likely consequence of the absence of ExEn
(Suppl. Figs. 5A, B). These results suggest that PELO is not
required for the formation of ExEn, but rather for the
maintenance of ExEn or for terminal differentiation to
functional ExEn that provides the embryo with growth
factors required for early embryonic development.PELO deficiency attenuates the activity of BMP
signaling in EBs
Studies in Drosophila showed that PELO regulates the
differentiation of germ stem cells in the ovary through BMP
signaling (Xi et al., 2005). Interestingly, defects in a
PrE-derived lineage, VE, and subsequent cavitation abnormal-
ities were observed during EB formation of ESCs treated with
BMP antagonists or ESCs overexpressing dominant-negative
BMPR1b receptor (Coucouvanis and Martin, 1999; Conley et
al., 2007; Rong et al., 2012). These observations, together
with impaired ExEn development seen in Pelo-deficient EBs,
led us to investigate the mRNA expression profile of genes
involved in TGF-β/BMP signaling in control and mutant EBs.
Gene expression analysis for TGF-β/BMP signaling components
in a PCR array revealed that 22 genes exhibit at least a 3-fold
difference in gene expression between Pelo-deficient and
control EBs (Suppl. Fig. 6 and Table 5). The changes in mRNA
levels of some differentially expressed genes were verified by
qRT-PCR (Fig. 3A). The mRNA levels of several BMP ligand
genes (Bmp-4 and -6) were significantly down-regulated in
Pelo-deficient EBs compared with control EBs (Fig. 3A).
Additionally, the expression of several BMP-target genes,
including Id1 and Id3, was down-regulated in PeloΔ/− EBs,
confirming the decreased activity of BMP signaling in mutant
EBs (Fig. 3A). In contrast, genes encoding Noggin and Lefty1,
which are known as potent antagonists of BMP and Nodal/
Activin signaling, respectively, were expressed highly in
mutant EBs to a level approximately more than 4–8 folds in
control EBs (Fig. 3A). The decreased activity of BMP signaling
in Pelo-deficient EBs was further confirmed by western blot
analysis of phosphorylated Smad1/5 (Fig. 3B).
The strong up-regulation of Noggin in Pelo-deficient EBs
was particularly interesting, because overexpression of
Noggin has been shown to affect the ExEn development
(Rong et al., 2012). Accordingly, we examined the effect
of conditioned medium collected from Pelo-deficient EB
culture on the differentiation of wild-type ESCs. While the
expression of ExEn-specific markers was not significantly
increased in Pelo-deficient EBs that were cultured in
conditioned medium collected from wild-type EB culture(data not shown), culture of wild-type ESCs with conditioned
medium collected from Pelo-deficient EB culture resulted in
a significant decrease in expression levels of ExEn-specific
markers (Fig. 3C). Moreover, we observed a decreased
expression of BMP-targeted genes Id1 and Id3, and a
significant elevation of the pluripotency-related genes
Oct4 and Nanog (Fig. 3C). Western blotting with equal
amount of concentrates of conditioned medium collected
from wild-type and mutant EB cultures confirmed that
Noggin was indeed expressed at higher levels in Pelo-null
than in wild-type EB culture (Fig. 3D). These results indicate
that increased levels of Noggin in conditioned medium
derived from Pelo-deficient EB culture are responsible for
the impaired ExEn development in wild-type EBs.
To confirm whether the decreased activity of BMP
signaling in Pelo-deficient cells is responsible for the
impaired ExEn development, mutant PeloΔ/− ESCs were
aggregated and cultured in serum replacement medium (SR
medium) supplemented with recombinant BMP4. Expression
analysis showed that the expression of BMP-target genes
Id1 and Id3, and ExEn markers was significantly induced
in BMP4-treated mutant EBs compared to that of BMP4-
untreated EBs (Fig. 3E). The ExEn formation as judged by
immunostaining further confirmed that the attenuated
activity of BMP signaling is indeed responsible for impaired
development of ExEn in Pelo-deficient EBs (Fig. 3F). A
significant decrease in the expression levels of Oct4 and
Nanog was observed in mutant EBs grown in culture medium
supplemented with BMP4 (Fig. 3E). These results suggest
that the persistent expression of pluripotency genes in
mutant EBs is not primarily due to PELO deficiency, but
rather to failed development of ExEn in these EBs. Further
experiments were performed to confirm previously reported
results (Conley et al., 2007), which showed that the ExEn
formation is disrupted in wild-type EBs grown in medium
supplemented with Noggin (Figs. 3G, H).
To further verify the attenuated activity of BMP signaling in
Pelo-null cells, we have established a BMP responsive reporter
cell line (PeloF/− BRE-FFLuc) by stably integrating BMP
responsive dual luciferase reporter construct pBFIR (Yadav
et al., 2012). The PeloF/− BRE-FFLuc cell lines were treated
with 4-OHT to generate mutant PeloΔ/− BRE-FFLuc ESCs. After
growing EBs from both PeloF/− BRE-FFLuc and PeloΔ/−
BRE-FFLuc cell lines in SR medium, they were further cultured
in medium supplemented either with or without BMP4. As
shown in Fig. 3I, the relative FFLuc activities were increased
significantly in BMP4-treated PeloF/− BRE-FFLuc and PeloΔ/−
BRE-FFLuc EBs. However, the relative FFLuc activity in control
cells was significantly higher than that of mutant cells. In
order to further examine the presence of BMP antagonists in
the conditioned medium of PeloΔ/− EBs, relative FFLuc
activities were measured in PeloF/− BRE-FFLuc EBs that were
treated for 12 h either with PeloΔ/− conditioned medium or
with PeloΔ/− conditioned medium and BMP4. We observed
that the relative FFLuc activity was significantly reduced in
control PeloF/− BRE-FFLuc EBs treated with PeloΔ/− condi-
tioned medium compared to untreated control (Fig. 3M). This
reduced activity was restored in control PeloF/− BRE-FFLuc
EBs, which were treated with both PeloΔ/− conditioned
medium and BMP4 (Fig. 3M). Collectively, these results further
confirm that the mutant PeloΔ/− EBs produce extracellular
modulators of BMP signaling activity.
Figure 3 Attenuated activity of BMP signaling in PeloΔ/− EBs. (A) Quantitative RT-PCR analysis for expression of BMP ligands,
BMP-target genes and antagonists (Noggin and Lefty 1) in control PeloF/− and mutant PeloΔ/− ESCs and EBs on day 5 of differentiation.
(B) Western blot analysis was performed to determine the expression levels of pSmad1/5 (pSmad) in control and mutant EBs (upper
panel). In the bar graph presented in the lower panel, expression levels of pSmad1/5 were normalized to that of α-tubulin (TUB).
Value is presented as mean ± SD. (C) Quantitative RT-PCR analysis for expression of ExEn, BMP-target genes and pluripotency markers
in control PeloF/−, mutant PeloΔ/− EBs as well as control PeloF/− EBs, which were cultured in conditioned medium derived from
Pelo-deficient EB cultures (PeloF/− + CM). Values of expression levels in A and C normalized to Hprt are presented as mean ± SD of
three experiments. Transcript levels of control ESCs and EBs in A and C, respectively, were expressed as 1.0. *, significantly different
from control ESCs (A) or EBs (C); p b 0.05. (D) Western blotting showing PeloΔ/−-conditioned medium containing higher levels of
Noggin than that in control-conditioned medium. Nog, 100 ng of recombinant Noggin was used as loading control. (E–H) Mutant
PeloΔ/− and control PeloF/− EBs, which were grown for 5 days in SRmedium supplemented with either 20 ng/ml BMP4 (D, E) or 150 ng/ml
Noggin (F, H), respectively, were subjected for RNA expression (E, G) and immunohistochemical analysis (F, H). (E, G) Quantitative
RT-PCR analysis for expression of BMP-target, ExEn and pluripotency markers in BMP4-treated PeloΔ/− (E) and Noggin-treated PeloF/− EBs
(G). Values of expression levels in E and G normalized to Hprt are presented as mean ± SD of three experiments. Transcript levels of
BMP4- and Noggin-untreated PeloΔ/− and PeloF/− in E and G, respectively, were expressed as 1.0. *, significantly different from control
BMP4-untreated PeloΔ/− EBs (E) and Noggin-untreated PeloF/− EBs (G); p b 0.05. (F, H) Paraffin sections of mutant PeloΔ/− and control
PeloF/− EBs were immunostained with anti-GATA4 antibody. Paraffin sections and RNAs prepared from PeloΔ/− and PeloF/− EBs, which
grown only in SRmedium,were used as untreated controls. Scale bars in F and H: 20 μm. (I) PeloF/− FFLuc and PeloΔ/− FFLuc Luc ESCswere
aggregated and grown in SR medium for 5 days and then treated for 12 h in SR medium supplemented either with or without BMP4.
(M) PeloF/− FFLuc EBs were cultured either with conditioned medium collected from mutant PeloΔ/− EBs or with conditioned medium
collected from mutant PeloΔ/− EBs supplemented with BMP4. Relative FFLuc activity (FFLuc/RRLuc) in I and M is presented as mean ± SD
of three experiments. *, significantly different from control cells; p b 0.05.
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69PELO regulates ExEn developmentPelo-depleted fibroblasts fail to generate iPSCs
To investigate whether Pelo is essential for the establishment
of induced pluripotency in somatic cells, we performed
reprogramming studies with mouse embryonic fibroblasts
(MEFs) generated from controls (Nanog-EGFP, PeloF/+
and PeloF/−), and mutant PeloΔ/− embryos. Delivery of
reprogramming factors, Oct3/4, Sox2, Klf4, and c-Myc
(OSKM) into control, Nanog-EGFP, and PeloF/+ MEFs
resulted in the appearance of AP-positive iPSC colonies
(Figs. 4A, B), which were morphologically indistinguishable
from ESC colonies and expressed pluripotency markers (data
not shown). Delivery of reprogramming factors into
Pelo-heterozygous PeloF/− MEFs revealed a reduced number of
AP-positive iPSC colonies (Figs. 4A, B). The established PeloF/−
iPSC colonies showed stereotypical colony morphology similar
to ESCs and expressed pluripotency markers, such as SSEA1,
Oct3/4, Sox2, and Nanog (Suppl. Figs. 7A, B). Interestingly,
PeloΔ/− MEFs failed to reprogram and showed no AP-positive
colonies (Figs. 4A, B). To verify whether overexpression of Pelo
can rescue the inability of PeloΔ/− to yield iPSCs, we performed
reprogramming studies by Pelo supplementation to the OSKM
factors (Figs. 4C, D). Notably, the addition of Pelo greatly
enhanced the iPSC generation from Nanog-EGFP, PeloF/+, and
PeloF/− MEFs, compared to OSKM alone (Figs. 4A–D). Moreover,
we obtained iPSCs from PeloΔ/−, confirming the rescueFigure 4 Pelo is required for somatic cell reprogramming. (A) Re
reprogramming with classical reprogramming factors (OSKM) (upper p
panel. (B) The number of AP-positive colonies in reprogramming pla
Data are shown as the mean ± SD of three experiments. *, sig
(C) Representative images of AP staining of various MEFs undergoin
together with Pelo (upper panel). High magnification of single colon
colonies in reprogramming plates shown in D was counted 14 days po
the mean ± SD of three experiments. *, significantly different from(Figs. 4C, D). To corroborate that Pelo deficiency does not
lead to the loss of pluripotency once it is established, as
observed for PeloΔ/− ESCs, we treated PeloF/− iPSCswith 4-OHT.
The homozygous deletion of Pelo in iPSCs (PeloΔ/−) revealed
smaller colony morphology and slower growth, as observed for
PeloΔ/− ESCs, but were positive for AP-staining and pluripotency
genes (Suppl. Fig. S7C and data not shown).BMP and MET are misregulated during the
reprogramming of Pelo-deficient fibroblasts
During the early phase of iPSC induction, an increase of BMP
activity is necessary to promote mesenchymal-to-epithelial
transition (MET) (Li et al., 2010; Samavarchi-Tehrani et al.,
2010). Hence, we comparatively analyzed the expression of
Bmp6 and Noggin between days 6 and 9 of reprogramming of
PeloF/+ and PeloΔ/− MEFs (Fig. 5A). The Bmp6 expression was
not upregulated in PeloΔ/− cells at day 6 of reprogramming,
but was highly up-regulated in PeloF/+ MEFs (Fig. 5A). In
agreement with these results, Noggin was dramatically
down-regulated in control cells by day 6 of reprogramming
(Fig. 5A). The slight change in expression levels of Bmp6
and Noggin in PeloΔ/− cells persisted through day 9 of
reprogramming (Fig. 5A). Simultaneously, we also analyzed
the expression levels of both mesenchymal and epithelialpresentative images of AP staining of various MEFs undergoing
anel). High magnification of single colonies is shown in the lower
tes was counted 14 days post-transduction with OSKM vectors.
nificantly different from control Nanog-GFP cells; p b 0.05.
g reprogramming with classical reprogramming factors (OSKM)
ies is shown in the lower panel. (D) The number of AP-positive
st-transduction with OSKM together with Pelo. Data are shown as
control Nanog-GFP cells; p b 0.05.
Figure 5 Expression of BMP signaling and MET components during the reprogramming of Pelo-deficient MEFs. (A) Expression of
Bmp6 and Noggin (Nog) in control PeloF/+ and mutant PeloΔ/− MEFs on days 0, 6 and 9 of reprogramming. Transcript levels in PeloF/−
MEFs on day 0 are shown as 1.0. (B) Line graphs showing the expression levels of mesenchymal and epithelial marker genes as well as
miRNAs on days 0, 6, and 9 of reprogramming.
70 G. Nyamsuren et al.marker genes and miRNAs, which promote the MET, during
the reprogramming of PeloΔ/− MEFs compared to control
MEFs (Fig. 5B). The expression of mesenchymal marker
genes (Zeb1, Zeb2, Slug, and Cdh2) was significantly
down-regulated in PeloF/+, but their expression was un-
changed or slightly reduced in PeloΔ/− MEFs even after
9 days of reprogramming (Fig. 5B). In line with these results,
epithelial marker genes (Ocln, Crb3, Epcam and Cdh1) were
highly up-regulated in reprogrammed control cells but not in
PeloΔ/− cells (Fig. 5B). The expression of miRNAs (miR-200a,
-200b, -205, and -429), which promote the MET process, was
highly upregulated in PeloF/+ cells, but not in PeloΔ/− cells
(Fig. 5B).Conserved function of mammalian PELO in NGD
To determine whether the role of PELO in NGD is also
conserved in mammalian cells, we analyzed control and
Pelo-deficient ESCs for expression of the EGFP reporter gene
(SL-EGFP) containing a stable stem loop (SL) located in frame
with EGFP (Fig. 6A). Northern blot analysis revealed that
EGFP-Zeo-fusion RNA was stable in mutant ESCs compared
with control ESCs (Fig. 6B), whereas no EGFP-fluorescence and
-protein were seen in either control or mutant ESCs (Fig. 6C
and data not shown). These results suggest that ribosome
stalled at stem-loop structure affects the translation of
reporter mRNA in both mutant and wild-type ESCs and that
the presence of PELO inwild-type ESCsmight trigger the decay
of EGFP mRNAs containing the stalled ribosomes. In contrast,the Pelo-deficient cells might be inefficient in activating the
NGD, thereby accumulating the reporter mRNAs.
Significant increase in expression levels of Noggin in
mutant EBs led us to examine the consequences of PELO
depletion on the mRNA stability of Noggin. We performed
actinomycin D chase experiments to monitor the post-
transcriptional changes in levels of Noggin mRNA in PeloF/−
and PeloΔ/− cells. The mRNA levels of Noggin were gradually
decreased after actinomycin D treatment with a similar time
course in control and Pelo-null cells (Fig. 6D), indicating
that the turnover of Noggin mRNA is not controlled by
PELO-dependent mRNA decay.Discussion
We previously reported that the conventional genetic
depletion of Pelo in mouse results in an embryonic lethality
at early post-implantation stages (Adham et al., 2003).
Here, we report that Pelo-null ESCs are continuously
propagated and retained their capacity to form undifferen-
tiated colonies at clonal densities, but fail to differentiate
into ExEn lineage in EBs. Conversely, overexpression of Pelo
in ESCs led to down-regulation of pluripotency-related genes
and a preferential activation of genes that regulate the
differentiation of ESCs into an ExEn cell lineage.
Upon the aggregation of ES cells in suspension, the outer
layer of developing EBs differentiates into ExEn, which
deposits extracellular matrix into the underlying basement
membrane (BM). Inside the BM, a primitive ectoderm layer is
Figure 6 Conserved function of mammalian PELO in NGD. (A) Schematic diagram of the pCAG-SL-EGFP-ZEO construct. The stem
loop (SL) sequence is located at the same reading frame with EGFP reporter gene. The internal ribosome entry site (IRES) is inserted
between EGFP and zeocin (Zeo) resistant gene. (B) Blot containing RNA from SL-EGFP-overexpressing control PeloF/− (L1), mutant
PeloΔ/− ES clones (L3–L5) and untransfected ESCs (L2) was hybridized with an EGFP probe. (C) Blot with protein extracts from
SL-EGFP-overexpressing PeloF/− (L2, L3) and PeloΔ/− ES clones (L4, L5) and Vsig-EGFP transgenic stomach as a control (L1) was probed
with anti-GFP antibody. The membrane was subsequently reprobed with α-tubulin antibody. (D) Noggin mRNA stability in control
PeloF/− and mutant PeloΔ/− EBs. Control and Pelo-deficient EBs were treated with actinomycin D, and total RNA was isolated after 0,
0.5, 2, 4 and 8 h of treatments. RNA blots were hybridized with Noggin cDNA probe. Expression levels of Nanog were normalized to
corresponding EF-2 mRNA levels. The normalized levels in control cells at time 0 were expressed as 1.00, and all other normalized
mRNA levels were graphed relative to that value (left panel).
71PELO regulates ExEn developmentdeveloped, and cavitation is formed in the core of the EBs
(Niwa, 2010). The developmental process of EBs mimics the
early embryonic stages of late blastocyst to egg cylinder
(E4.5–E6.5). Both formation of ExEn and cavitation have
been shown to be regulated by the BMP signaling pathway
in mouse embryos and EBs. Thus, inhibition of BMP sig-
naling by expression of a dominant-negative BMP receptor,
down-regulation of Bmp6 expression in ectodermal cells or
addition of the BMP antagonist Noggin in culture prevents
the development of ExEn in EBs (Coucouvanis and Martin,
1999; Conley et al., 2007; Rong et al., 2012). A significant
decrease in the expression levels of BMP-targeted genes,
phosphorylated Smad1/5, and the overexpression of Noggin
in Pelo-deficient EBs suggest that PELO regulates differen-
tiation toward ExEn lineage through the activation of BMP
signaling. These results were supported by the observations
of restored ExEn development in mutant EBs grown in
medium supplemented with BMP4. Further, the negative
effect of conditioned medium collected from mutant EBs onthe ExEn formation in wild-type EBs and the significant
decrease of luciferase activity in the BMP responsive
reporter cell line indicate that mutant EBs secrete extracel-
lular modulators which attenuate the BMP signaling activity.
Several factors regulate the activity of BMP signaling at
intracellular and extracellular levels. The responsiveness of
wild-type and mutant cells to Noggin and BMP4 treatment
excludes the role of PELO in regulation of the intracellular
modulators of BMP signaling. Extracellular modulators such
as Noggin and Chordin antagonize the BMP signal (Piccolo et
al., 1996; Zimmerman et al., 1996). Acute overexpression of
Noggin in Pelo-null EBs led to suggest that PELO regulates
the BMP signaling by negatively regulating Noggin expression
at either transcriptional or post-transcriptional levels.
Cytoplasmic localization of PELO in human and Drosophila
cells (Xi et al., 2005; Burnicka-Turek et al., 2010) rules out
that PELO directly regulates Noggin at the transcriptional
level. In addition, the fact that the conserved role of PELO in
NGD and deletion of PELO do not affect the stability of
72 G. Nyamsuren et al.Noggin transcripts suggests that PELO indirectly down-
regulates Noggin through controlling stability of transcrip-
tion factors regulating Noggin expression. Taken together,
these results led us to conclude that the reduced BMP
signaling in Pelo-null EBs accounts for the observed defect in
ExEn differentiation. In support of our results, impaired ExEn
development as a result of the affected BMP signaling was
also shown in Smad4-deficient EBs (Sirard et al., 1998).
Moreover, BMP-mediated MET activation was shown to be
essential for the induction of pluripotency in somatic
cells (Li et al., 2010; Samavarchi-Tehrani et al., 2010). The
failure of Pelo-deficient MEFs to activate BMP signaling
during reprogramming reinforces that PELO is an indispens-
able component for the activation of BMP signaling during
the establishment of pluripotency and ExEn cell lineage
commitment.
The failure of Pelo-null ESCs to undergo ExEn differentia-
tion was accompanied by a significant decrease in the
expression levels of the transcription factors Gata4, Gata6
and Hnf4, which are involved in differentiation and functions
of ExEn lineage. Similarly, ESCs lacking either Gata4 or Gata6
failed to form the endodermal outer layer (Soudais et al.,
1995; Morrisey et al., 1998). Like the overexpression of Gata4
and Gata6 (Fujikura et al., 2002), forced expression of Pelo
directs differentiation of ExEn lineage in ESCs. Remarkably,
the expression levels of the Pelo transcript were approxi-
mately 1.7-fold higher than that of wild-type ESCs. However,
this modest change was sufficient to induce differentiation of
ESCs into cells positive for ExEn markers, suggesting a
quantitative effect of Pelo on ESC differentiation.
The recovery of ExEn outer layer and down-regulation of
pluripotent genes in mutant EBs grown in medium supple-
mented with BMP4 indicate that the failure of Pelo-null cells
to down-regulate pluripotency-related genes in EBs is not a
result of cell-autonomous effect, but rather to failed signals
from surrounding ExEn that induce the differentiation
program. These findings are in agreement with the results
showing that the persistence of pluripotent cells in Dido
3-deficient EBs is a result of the failed ExEn development
(Futterer et al., 2012). The differentiation of Pelo-deficient
ESCs to different germ layers in teratoma assay and to ExEn
in response to retinoic acid confirms that the loss of PELO
does not impair the differentiation of ESCs. Further in vivo
studies showed the presence of ExEn in Pelo-null embryos at
E6.5 and embryonic lethality at E7.5. These results led us to
suggest that PELO is not required for the induction of ExEn,
but rather for the maintenance or terminal differentiation
toward functional visceral endoderm. Like Pelo mutants,
targeted deletion of Gata6, Dab2 and Hnf4 genes, which are
initially expressed in ExEn, resulted in early embryonic
lethality. Despite the failed development of ExEn in the
Gata6-, Dab2- and Hnf4-deficient EBs, ExEn is formed in
their mutant E6.5 embryos (Duncan et al., 1997; Morrisey et
al., 1998; Yang et al., 2002). These studies have attributed
the affected development of mutant embryos to deficiency
of functional ExEn. Restoration of ExEn development in
Pelo-null EBs by supplementation of RA led us to suggest that
RA-regulated pathway might have induced the ExEn differ-
entiation in Pelo-null embryo at E6.5.
Our experiments showed that PELO deficiency inhibits
the reprogramming of somatic cells, whereas the overex-
pression of Pelo along with other reprogramming factorspromotes efficient reprogramming. These results suggest
that PELO is required during the initiation stage of
reprogramming, and its loss impairs the process. Recent
reports revealed that increased BMP signaling during the
initial stages of reprogramming promotes the MET (Li et al.,
2010; Samavarchi-Tehrani et al., 2010). The failure of BMP
signaling activation in PeloΔ/− cells undergoing reprogramming
suggests a critical role of PELO in the early phase of somatic
reprogramming, probably by activating BMP signaling. Consis-
tent with the absence of reprogramming in PeloΔ/− cells, the
expression levels of mesenchymal and epithelial markers in
PeloΔ/− reprogrammed cells were not significantly altered
compared to those in parental PeloΔ/− MEF cells.
Collectively, our results highlight the role of PELO in the
activation of BMP signaling in order to drive the establishment
of pluripotency and ExEn lineage. Further studies aimed at the
identification and characterization of protein complexes
containing PELO and how PELO activates BMP signaling will
shed light on the function of PELO in these processes.Acknowledgments
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